Search

Changes to Formulary as of 8th August 2018:

BNF Category Number

Product/indication

Detail of change

6.5.2.2

Tolvaptan 

Entry on the formulary should be updated  as per the NoT/Tees formulary.

6.1

Insulin Aspart (Fiasp)

Added as RED drug and added link to MHRA letter to HCP

8.2.3

Avelumab

Added as RED drug and added link to NICE TA517

10.1.3

Tocilizumab

Added link to NICE TA518

8.1

Pembrolizumab

Added link to NICE TA518

8.1

Atezolizumab

Added link to NICE TA519

13.5

Guselkumab

Added link to NICE TA521

5.1.9

Ethambutol

400mg in 5ml added as green

5.1.9

Pyrazinamide

500mg in 5ml added as green

5.1.9

Isoniazid

50mg in 5ml added as green

2.5.1

Sildenafil

Added as a RED drug for Raynaud's

7.3.2.3

Levosert

License change from 3 to 4 years

3.2

Seretide evohaler and accuhaler

Removed from formulary

3.2

Fobumix

Added as GREEN drug

3.2

Sereflo

Added as GREEN drug

1.9.1

Obeticholic Acid

Added link to MHRA DSU Guidance

4.8.1, 4.7.4.2, 4.2.3

Sodium valproate

Added links to MHRA DSU Guidance

3.1.2

Tiotropium (Braltus)

Added link to MHRA DSU Guidance

6.1.1.2

Insulin Degludec

Added link to MHRA letter to HCP

15

 

New formulary chapter added